UNSPSC 51422431: Hydrocortisone phosphate

This classification denotes a therapeutic hydrocortisone with the molecular formula C21H31O8P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Y87E22X71, chemically known as pregn-4-ene-3,20-dione, 11, 17-dihydroxy-21- (phosphonooxy)-, (11.beta.)- but more generally known as hydrocortisone phosphate, which bears US NIH Compound Identifier 3645. Most nations, for tariff and trade purposes, schedule hydrocortisone phosphate under HS 29372100 and SITC 54153.

As of Q4 2014, HYDROCORTISONE PHOSPHATE remains US FDA's Preferred Term for this commodity. Hydrocortisone phosphate bears US NLM identifiers UMLS ID C0056383 and NCI Concept Code C83763. SMILES: C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COP(=O)(O)O)O)C)O.

UNSPSC 51422431 Hydrocortisone phosphate is a Commodity code that nominally covers pharmaceutical-grade hydrocortisone phosphate products; however, the recent state and local solicitation activity under this code shows no alignment with the code's stated scope. Seminole County, Florida posted an IFB in June 2026 for Naloxone and Safe Drug Deactivation Systems — a misclassified procurement bearing no relationship to hydrocortisone phosphate. The code shows little relevant recent activity and appears to carry a tagging error at the point of solicitation posting.

This mismatch between the code's pharmaceutical scope and the actual procurement being sought suggests the code is not a current vehicle for state and local hydrocortisone phosphate procurement. Business development professionals evaluating opportunities under this code should verify classification accuracy with issuing bodies before investing pursuit resources. The single recent opportunity identified does not represent meaningful market activity in hydrocortisone phosphate sourcing at the state and local level.